LABORATORY RESEARCH USE ONLY β This compound is NOT for human consumption, veterinary use, or therapeutic applications.
Metabolic PeptidesLipolysis Research㪠RUO
Fragment 176-191
Molecular Data
Formula
C78H125N19O23S2
Mol. Weight
1817.12 Da
CAS Number
221231-10-3
Purity
β₯98% (HPLC)
Appearance
White lyophilized powder
Storage
-20Β°C, desiccated
Research Overview
HGH Fragment 176-191 is the C-terminal fragment of human growth hormone representing the lipolytic domain. It retains fat metabolism activity without growth-promoting effects.
Mechanism of Action
Activates beta-3 adrenergic receptors in adipose tissue, stimulating hormone-sensitive lipase (HSL) activity and inhibiting acetyl-CoA carboxylase.
Research Applications
Lipolysis pathway studies, adipocyte biology, metabolic syndrome modeling, comparative hGH fragment analysis, obesity research.
Key Research Findings
12.5x more potent for lipolysis than hGH in adipocyte cultures. No effect on glucose metabolism or cell proliferation.
MANDATORY DISCLAIMER: Fragment 176-191 as referenced on this page is strictly for in-vitro laboratory research and forensic applications only. It is NOT for human consumption, veterinary use, diagnostic purposes, therapeutic applications, or any form of bodily introduction. Any reference to research outcomes pertains exclusively to controlled laboratory settings. Researchers must comply with all applicable local, state, and federal regulations.
